These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34152967)

  • 1. Risks and Preventive Strategies for Clostridioides difficile Transmission to Household or Community Contacts during Transition in Healthcare Settings.
    Asgary R; Snead JA; Wahid NA; Ro V; Halim M; Stribling JC
    Emerg Infect Dis; 2021 Jul; 27(7):1776-1782. PubMed ID: 34152967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
    Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members.
    Miller AC; Arakkal AT; Sewell DK; Segre AM; Pemmaraju SV; Polgreen PM;
    Emerg Infect Dis; 2022 May; 28(5):932-939. PubMed ID: 35447064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL
    Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.
    Silva A; Du T; Choi KB; Pelude L; Golding GR; Hizon R; Lee BE; Chow B; Srigley JA; Hota SS; Comeau JL; Thampi N;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):222-225. PubMed ID: 36718660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    Slimings C; Riley TV
    J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of environmental cleaning bundles on reducing healthcare-associated Clostridioides difficile infection: a systematic review and meta-analysis.
    Chau JPC; Liu X; Lo SHS; Chien WT; Wan X
    J Hosp Infect; 2020 Dec; 106(4):734-744. PubMed ID: 32861741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008-2015
    Zanichelli V; Garenc C; Villeneuve J; Moisan D; Frenette C; Loo V; Longtin Y;
    Emerg Infect Dis; 2020 Jun; 26(6):1291-1294. PubMed ID: 32441632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Clostridioides difficile infection in hospitalized patients in Spain: An eight-year review (2012-2019).
    Asensio Á; Vallejo-Plaza A; Parra LM; Ortí-Lucas R; Salcedo I; Ramos A; Cantero M;
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Mar; 40(3):125-130. PubMed ID: 35249672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to prevent adverse outcomes following
    Rauseo AM; Olsen MA; Reske KA; Dubberke ER
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis.
    Dong N; Li ZR; Qin P; Qiang CX; Yang J; Niu YN; Niu XR; Liu XX; Wang WG; Wen BJ; Ouyang ZR; Zhang YL; Zhao M; Li JYR; Zhao JH
    J Hosp Infect; 2022 Dec; 130():112-121. PubMed ID: 36108754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 19. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.
    Sahrmann JM; Olsen MA; Stwalley D; Yu H; Dubberke ER
    Clin Infect Dis; 2023 Mar; 76(5):809-815. PubMed ID: 36285546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021).
    Lanzas C; Jara M; Tucker R; Curtis S;
    Anaerobe; 2022 Apr; 74():102541. PubMed ID: 35217149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.